Robitussin Deceptive Marketing Image

$4.5M Non-Drowsy Robitussin Class Action Settlement

If you purchased a “non-drowsy” Robitussin product, you may be eligible for part of a $4.5 million settlement. Learn if you qualify and how to submit a claim today.

  • Corporate Lawsuits

Last Update

  • March 31, 2025
lawsuitlike
lawsuitlike
lawsuitlike

About the Robitussin Class Action Settlement

A $4.5 million settlement has been reached in the 2022 class action lawsuit that accused drug manufacturer Haleon of falsely advertising its popular cough medicine, Robitussin. The company purportedly marketed the well-known cough syrup as “non-drowsy" despite it containing an active ingredient (dextromethorphan or DM) that can cause sleepiness. 

The pharmaceutical giant continues to deny the deceptive marketing allegations but chose to settle the class action complaint rather than face further litigation. This gives affected consumers the chance to receive compensation for purchases they made based on the dishonest labeling.

Individuals who bought qualifying Robitussin products for personal and at-home use can now claim their portion of the settlement. Read on to learn more about the lawsuit, payout amounts, settlement deadlines—and how to qualify and submit a claim today. 

 

What is the Focus of the Lawsuit?

The lawsuit accused Haleon, formerly known as GlaxoSmithKline Consumer Healthcare, of falsely advertising certain Robitussin cough medicines. The company labeled the products as “non-drowsy,” regardless of them containing dextromethorphan (DM). 

Drowsiness is a well-documented side effect of DM, making Haleon’s choice to market the cough syrup as “non-drowsy” puzzling. Even worse, this alleged misrepresentation may have put consumers at risk who relied on the medication while driving, operating machinery, or completing other tasks that required full mental alertness.

 

Who is the Settlement for? 

The Robitussin class action settlement is for anyone who, between February 16, 2016, and January 21, 2025, purchased any of the qualifying “non-drowsy” Robitussin products listed in the following section. The cough medicine must have been purchased in the United States for personal or home use. 

Who is Eligible for the Robitussin Class Action Settlement?

To qualify to submit a claim for your share of the Robitussin class action settlement, you must meet several requirements. These include:

  • You must have purchased an eligible “non-drowsy” Robitussin product for household use between February 16, 2016, and January 21, 2025.
  • You must have purchased any qualifying products in the United States.

Covered “non-drowsy” Robitussin products include: 

  • Robitussin Cough+Chest Congestion DM Maximum Strength Syrups
  • Robitussin Cough+Chest Congestion DM Maximum Strength / Nighttime Cough DM Maximum Strength Day & Night Value Pack Syrups
  • Robitussin Cough+Chest Congestion DM Maximum Strength Liquid-Filled Capsules
  • Robitussin Cough+Chest Congestion DM Syrups
  • Children’s Robitussin Cough & Chest Congestion DM Syrups
  • Children’s Robitussin Cough & Chest Congestion DM / Nighttime Cough Long-Acting DM Day & Night Value Pack Syrups
  • Robitussin Sugar-Free Cough+Chest Congestion DM Syrups
  • Robitussin Honey Cough+Chest Congestion DM Maximum Strength Syrups
  • Robitussin Honey Cough+Chest Congestion DM Maximum Strength / Nighttime Cough DM Maximum Strength Day & Night Value Pack Syrups
  • Robitussin Elderberry Cough+Chest Congestion DM Maximum Strength Syrups
  • Children’s Robitussin Elderberry Cough & Chest Congestion DM Syrups
  • Robitussin Severe Multi-Symptom Cough Cold + Flu CF Maximum Strength Syrups
  • Robitussin Severe Multi-Symptom Cough Cold + Flu CF Maximum Strength / Nighttime Severe Multi-Symptom Cough Cold + Flu CF Maximum Strength Day & Night Value Pack Syrups
  • Robitussin Severe Cough + Sore Throat CF Maximum Strength Syrups
  • Robitussin Honey Severe Cough Flu + Sore Throat CF Maximum Strength Syrups
  • Robitussin Honey Severe Cough Flu + Sore Throat CF Maximum Strength / Nighttime Severe Cough Flu + Sore Throat CF Maximum Strength Day & Night Value Pack Syrups
  • Robitussin Multi-Symptom Cold CF Syrups
  • Children’s Robitussin Cough & Cold CF Syrups
  • Robitussin Long-Acting CoughGels
  • Robitussin 12 Hour Cough Relief Extended-Release Grape Syrups
  • Robitussin 12 Hour Cough Relief Extended-Release Orange Syrups

 

How Do I Submit a Claim?

Consumers can submit a claim for the Robitussin class action settlement by completing a claim form here. To complete this straightforward form, you’ll need to enter personal details like your name, address, email address, and phone number. Finally, you’ll choose to enclose any optional proof of purchase and indicate your preferred method to receive a settlement payout.

You don’t need to provide proof of purchase to receive compensation, but doing so allows you to make a greater number of claims. With proof of each purchase, every household is entitled to make up to three claims. Even if you no longer have proof of purchase, you’re still eligible to make one claim per household.

For full settlement terms and qualification standards, you can reference the class settlement notice and related paperwork. These documents can help you further understand the settlement qualifications and steps to submitting a claim. This page is not intended to provide legal advice. 

How Much Will I Receive?

Robitussin class action settlement payouts are expected to be between $1.50 and $4.75 per claim. However, these amounts are just estimates—the final payout amount won’t be determined until all submitted claims have been processed.  

 

Deadline to File a Claim

All claim forms must be submitted by May 12, 2025, in order to be processed. You won’t be able to submit a claim after this date, so it’s important to complete the form on time to preserve your share of the Robitussin class action settlement.

 

Robitussin Class Action Settlement Fast Facts

Deadline to File a Claim: May 12, 2025

Estimated Payout Amount: $1.50 to $4.75 per claim; final amount determined by number of claims submitted

Proof Needed: None required, but proof of purchase allows you to make up to 3 claims per household 

Where to File a Claim: https://www.nondrowsyrobitussinsettlement.com/home

 


Frequently Asked Questions (FAQ)

The lawsuit accuses Haleon (formerly GlaxoSmithKline Consumer Healthcare) of false advertisement. Allegedly, the pharmaceutical manufacturer deceptively marketed certain Robitussin cough medicine products as “non-drowsy” despite them containing an ingredient known to cause sleepiness.

Robitussin’s active ingredient, dextromethorphan (DM), is singled out in the lawsuit. This compound has a recognized side effect of drowsiness, making Haleon’s “non-drowsy” claims incorrect.

All claim forms must be completed and received by May 12, 2025.

This is an advertisement. OnlyClassActions is not a law firm or referral service, and we do not provide legal advice. OnlyClassActions provides a free service for individuals seeking legal representation, and we do not charge you to be connected with an attorney. We do not recommend or endorse any attorneys that pay to participate. OnlyClassActions utilizes a pool of attorneys in each jurisdiction, and attorneys are selected through a round-robin process without our evaluating your legal situation when selecting which attorney will receive your information. OnlyClassActions makes no representation about the quality of legal services or the qualifications of any attorney participating in our pool. Information you submit will be shared with third-party attorney(s). An attorney-client relationship is not formed when you submit information through the form. Hiring a lawyer is a critical decision and should not be predicated solely on comments, advertisements, or other content found on any website. You are under no obligation to retain a lawyer who contacts you through this service.

Add Comment




footer-logo

Lawsuits & Settlements

View All SettlementsLatest Class Action NewsAbout Us

Subscribe

Join our newsletter to stay up to date on cases and settlements.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

© 2024 OnlyClassActions. All rights reserved.

Privacy PolicyTerms of Service

Cookie Consent

FacebookInstagramTwitter